GSK plc (LSE/NYSE: GSK) today announced that the European Medicine Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion to support the approval of ...
Investing.com -- GSK plc (LSE:GSK) announced Tuesday that its Shingrix vaccine has received a positive opinion from the European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) ...
GSK plc announced that the European Medicine Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion to support the approval of Shingrix (GSK’s Recombinant ...
The MarketWatch News Department was not involved in the creation of this content.-- VYVGART(R) SC is first and only neonatal Fc receptor blocker approved to treat CIDP -- Authoriz ...
ZURICH, October 21, 2025--(BUSINESS WIRE)--Polpharma Biologics today announced Ranivisio® PFS (ranibizumab biosimilar pre-filled syringe), is now commercially available in France. Ranivisio® is the ...
Polpharma Biologics today announced Ranivisio® PFS (ranibizumab biosimilar pre-filled syringe), is now commercially available in France. Ranivisio® is the first Lucentis® biosimilar which is offered ...
ZURICH--(BUSINESS WIRE)--Polpharma Biologics today announced Ranivisio® PFS (ranibizumab biosimilar pre-filled syringe), is now commercially available in France. Ranivisio® is the first Lucentis® ...
GSK (GSK) announced that the European Medicine Agency’s, EMA, Committee for Medicinal Products for Human Use, CHMP, has issued a positive opinion to support the approval of Shingrix in a prefilled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback